Medical Science Liaisons (MSLs) serve as the bridge between pharmaceutical companies, healthcare professionals and the scientific community. Their impact reverberates across the entire healthcare ecosystem as they are essential for fostering scientific dialogue, driving evidence-based medicine and advancing patient outcomes.
In this new article by Susan Giacalone, she highlights the significant impact MSLs can have on the success trajectory of newly-launched products. The article also includes a case study that demonstrates how a robust medical affairs operation and MSL team helped build a strategic partnership to overcome industry challenges. It further discusses three key elements necessary to establish high-impact Medical Affairs and MSL teams: Strategic Partnership, Cross-Collaboration and Business Acumen.
To gain a deeper understanding of these concepts and explore the full breadth of insights, click below to download the full article.
Author
Susan leads field medical efforts for EVERSANA. As a leader in the life sciences industry, she brings more than 20 years of medical affairs experience across multiple therapeutic areas, including oncology, hepatology and rare…